Publications by authors named "Anna Galli"

Splicing factor SF3B1 mutations are frequent somatic lesions in myeloid neoplasms that transform hematopoietic stem cells (HSCs) by inducing mis-splicing of target genes. However, the molecular and functional consequences of SF3B1 mutations in human HSCs and progenitors (HSPCs) remain unclear. Here, we identify the mis-splicing program in human HSPCs as a targetable vulnerability by precise gene editing of SF3B1 K700E mutations in primary CD34+ cells.

View Article and Find Full Text PDF

Background: The Molecular International Prognostic Scoring System (IPSS-M) is the new gold standard for diagnostic outcome prediction in patients with myelodysplastic syndromes (MDS). This study was designed to assess the additive prognostic impact of dynamic transfusion parameters during early follow-up.

Methods: We retrieved complete transfusion data from 677 adult Swedish MDS patients included in the IPSS-M cohort.

View Article and Find Full Text PDF

In contact lens (CL) wear, dehydration needs to be tailored to avoid dryness and related symptoms. In this view, this work aims to assess and compare the in-vitro dehydration kinetics of five CL materials, including the newly developed Kalifilcon A CL. At 36 °C and 60% relative humidity, the in-vitro dehydration kinetics of the different CLs were compared using a gravimetric method.

View Article and Find Full Text PDF

Systematic studies of germ line genetic predisposition to myeloid neoplasms in adult patients are still limited. In this work, we performed germ line and somatic targeted sequencing in a cohort of adult patients with hypoplastic bone marrow (BM) to study germ line predisposition variants and their clinical correlates. The study population included 402 consecutive adult patients investigated for unexplained cytopenia and reduced age-adjusted BM cellularity.

View Article and Find Full Text PDF
Article Synopsis
  • A study involving 3131 patients with myeloproliferative neoplasms (MPNs) found that 6.4% had a family history of a second hematological malignancy (HM).
  • The prevalence of second HM cases was consistent across different MPN subtypes, genders, and driver mutations.
  • Younger patients diagnosed with MPN (under 45 years) were more likely (8.5%) to have a relative with HM compared to older patients (5.5%), indicating a possible genetic link for early-onset cases.
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers found that certain rare genetic variants in TLR7, especially in young men with severe COVID-19, led to weakened immune responses, including reduced signaling and interferon production.
  • * RNA sequencing studies showed significant dysfunction in the TLR7 pathway among patients with specific TLR7 variants, revealing decreased levels of important immune response genes after stimulation.
View Article and Find Full Text PDF
Article Synopsis
  • Diagnosing myeloid malignancies is difficult and often varies between doctors, so researchers created a machine learning model using clinical and next-generation sequencing (NGS) data from an international group of patients to assist in the diagnosis without relying on bone marrow biopsies.
  • The model shows strong performance and reveals that it considers similar factors as human clinicians do during diagnosis.
  • Additionally, the study explores connections between NGS results and important clinical traits, using machine learning to better understand the relationships between clinical and genetic information.
View Article and Find Full Text PDF

Clonal hematopoiesis results from somatic mutations in cancer driver genes in hematopoietic stem cells. We sought to identify novel drivers of clonal expansion using an unbiased analysis of sequencing data from 84,683 persons and identified common mutations in the 5-methylcytosine reader, , as well as in , , and . We also identified these mutations at low frequency in myelodysplastic syndrome patients.

View Article and Find Full Text PDF
Article Synopsis
  • - Acute leukemia of ambiguous lineage (ALAL) is a rare and poorly understood type of leukemia with no established treatment guidelines due to its variability and lack of clinical trials.
  • - A study of 10 ALAL cases revealed a high frequency of myeloid-gene mutations, particularly RUNX1 mutations, which are linked to an undifferentiated phenotype and lineage ambiguity.
  • - The findings suggest that ALAL, particularly those with undifferentiated characteristics, may be genetically more similar to acute myeloid leukemia than acute lymphoblastic leukemia, indicating that treatment approaches might need to focus on AML-based therapies.
View Article and Find Full Text PDF

Background: COVID-19 is a multisystem disease complicated by respiratory failure requiring sustanined mechanical ventilation (MV). Prolongued oro-tracheal intubation is associated to an increased risk of dysphagia and bronchial aspiration. Purpose of this study was to investigate swallowing disorders in critically ill COVID-19 patients.

View Article and Find Full Text PDF

Purpose Of Review: Clinical and experimental studies have uncovered relevant clinical implications of clonal hematopoiesis. However, the true magnitude of this process, clonal dynamics over time and mechanisms of progression into overt malignancy remain to be largely elucidated. In this article, the consequences of clonal hematopoiesis, its significance in the context of cytopenia, and its implications in the clinical management of patients with myeloid malignancies are reviewed and discussed.

View Article and Find Full Text PDF
Article Synopsis
  • Clonal cytopenia of undetermined significance (CCUS) is linked to a higher risk of developing myeloid neoplasms, and a study of various patient cohorts revealed that about 30% of individuals with idiopathic cytopenia carry genetic mutations associated with CCUS.
  • The presence of clonal hematopoiesis (CH) was found in nearly 20% of non-anemic individuals and around 28% of those with unexplained anemia, with distinct mutation patterns indicating differing levels of disease progression risk.
  • Two main mutation clusters were identified, with one showing isolated DNMT3A mutations and the other characteristic combinatorial patterns, impacting both overall survival rates and the likelihood of progression to myeloid ne
View Article and Find Full Text PDF

Reflectance Spectroscopy (RS) and Fiber Optics Reflectance Spectroscopy (FORS) are well-established techniques for the investigation of works of art with particular attention to paintings. Most modern museums put at the disposal of their research groups portable equipment that, together with the intrinsic non-invasiveness of RS and FORS, makes possible the in situ collection of reflectance spectra from the surface of artefacts. The comparison, performed by experts in pigments and painting materials, of the experimental data with databases of reference spectra drives the characterization of the palettes and of the techniques used by the artists.

View Article and Find Full Text PDF

The incidence and prognosis of clonal hematopoiesis in patients with isolated neutropenia among patients with idiopathic cytopenia of undetermined significance (ICUS), known as ICUS-N or chronic idiopathic neutropenia (CIN) patients, is poorly defined. The current study sought to investigate the frequency and clinical significance of mutations of genes implicated in myeloid malignancies using next-generation sequencing in patients with CIN (n = 185) with a long follow-up. We found that 21 (11.

View Article and Find Full Text PDF

Daratumumab is a monoclonal antibody directed against the transmembrane glycoprotein CD38 expressed on plasma cells and lymphoplasmocytes, with a proven efficacy in multiple myeloma. Here we show its clinical efficacy in a patient with cold agglutinin disease (CAD) relapsed after multiple lines of therapy. CAD is caused by cold reactive autoantibodies that induce complement mediated hemolysis and peripheral circulatory symptoms.

View Article and Find Full Text PDF

In the age of personalized medicine, genetic testing by means of targeted sequencing has taken a key role. However, when comparing different sets of targeted sequencing data, these are often characterized by a considerable lack of harmonization. Laboratories follow their own best practices, analyzing their own target regions.

View Article and Find Full Text PDF

Somatic mutations in splicing factor genes frequently occur in myeloid neoplasms. While SF3B1 mutations are associated with myelodysplastic syndromes (MDS) with ring sideroblasts, SRSF2 mutations are found in different disease categories, including MDS, myeloproliferative neoplasms (MPN), myelodysplastic/myeloproliferative neoplasms (MDS/MPN), and acute myeloid leukemia (AML). To identify molecular determinants of this phenotypic heterogeneity, we explored molecular and clinical features of a prospective cohort of 279 SRSF2-mutated cases selected from a population of 2663 patients with myeloid neoplasms.

View Article and Find Full Text PDF

Uncovering the underdrawings (UDs), the preliminary sketch made by the painter on the grounded preparatory support, is a keystone for understanding the painting's history including the original project of the artist, the (an underlying image in a painting providing evidence of revision by the artist) or the possible presence of co-workers' contributions. The application of infrared reflectography (IRR) has made the dream of discovering the UDs come true: since its introduction, there has been a growing interest in the technology, which therefore has evolved leading to advanced instruments. Most of the literature either report on the technological advances in IRR devices or present case studies, but a straightforward method to improve the visibility of the UDs has not been presented yet.

View Article and Find Full Text PDF

Double knockout of the two miR-15/16 loci in mouse resulted in the development of acute myeloid leukemia (AML). This result suggested that, at least, a fraction of human AMLs could be due to a similar mechanism. We analyzed the role of the two miR-15/16 clusters in 93 myelodysplastic syndrome (MDS) patients divided in three subgroups: patients with MDS, patients with MDS before transforming into AML (MDS-T), and patients with AML evolving from MDS (MDS-AML).

View Article and Find Full Text PDF

The spliceosome accurately promotes precursor messenger-RNA splicing by recognizing specific noncoding intronic tracts including the branch point sequence (BPS) and the 3'-splice-site (3'SS). Mutations of Hsh155 (yeast)/SF3B1 (human), which is a protein of the SF3b factor involved in BPS recognition and induces altered BPS binding and 3'SS selection, lead to mis-spliced mRNA transcripts. Although these mutations recur in hematologic malignancies, the mechanism by which they change gene expression remains unclear.

View Article and Find Full Text PDF
Article Synopsis
  • Lymphoplasmacytic lymphoma (LPL) typically presents with an IgM paraprotein, but a study examined 45 rare non-IgM cases, revealing unique clinical features and differences from Waldenström's Macroglobulinemia (WM) patients.
  • Non-IgM LPL had a higher percentage of females and more cases of lymphadenopathy and splenomegaly, while showing lower rates of serum monoclonal protein and bone marrow infiltration compared to WM.
  • Both groups had similar five-year overall survival rates of 84%, though non-IgM LPL patients were more likely to be treated with anthracycline-based regimens.
View Article and Find Full Text PDF

Diagnostic criteria for hypoplastic myelodysplasic syndrome (h-MDS) have not been clearly established, making the differential diagnosis from other bone marrow failure syndromes (BMF) challenging. In this study, we aimed to delineate clinical, histopathological, and molecular features of h-MDS, based on a large and well-annotated cohort of patients with bone marrow (BM) hypocellularity. The study included 534 consecutive adult patients with hypocellular BM (278 h-MDS and 136 aplastic anemia), and 727 with normo- or hypercellular MDS (n-MDS).

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Anna Galli"

  • - Anna Galli's recent research focuses on myeloid neoplasms, with studies addressing risk prediction for clonal cytopenia, the impact of splicing factor mutations on hematopoietic stem cells, and the prognostic value of transfusion patterns in myelodysplastic syndromes.
  • - Her investigations reveal significant findings such as the identification of somatic mutations and their role in hematopoietic transformation, with potential therapeutic targets to improve outcomes for patients with mutations like SF3B1.
  • - Galli's work combines genomic analysis with clinical data to develop predictive models and understand genetic predispositions in hematological malignancies, contributing to better diagnosis and treatment strategies in the field.